Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:37PM ET
1.61
Dollar change
+0.11
Percentage change
7.00
%
Index- P/E- EPS (ttm)-7.75 Insider Own40.57% Shs Outstand15.71M Perf Week2.23%
Market Cap25.21M Forward P/E- EPS next Y-2.96 Insider Trans0.00% Shs Float9.33M Perf Month-13.24%
Income-51.21M PEG- EPS next Q-1.12 Inst Own7.60% Short Float0.75% Perf Quarter-37.30%
Sales0.00M P/S- EPS this Y42.78% Inst Trans4.70% Short Ratio0.77 Perf Half Y-45.22%
Book/sh-0.37 P/B- EPS next Y31.73% ROA-159.98% Short Interest0.07M Perf Year-83.05%
Cash/sh0.59 P/C2.73 EPS next 5Y- ROE-293.96% 52W Range1.36 - 10.12 Perf YTD-36.81%
Dividend Est.- P/FCF- EPS past 5Y10.18% ROI- 52W High-84.15% Beta1.27
Dividend TTM- Quick Ratio0.78 Sales past 5Y0.00% Gross Margin- 52W Low18.01% ATR (14)0.14
Dividend Ex-Date- Current Ratio0.78 EPS Y/Y TTM-14.00% Oper. Margin0.00% RSI (14)46.56 Volatility7.56% 8.41%
Employees35 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.60
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q7.31% Payout- Rel Volume1.94 Prev Close1.50
Sales Surprise- EPS Surprise18.50% Sales Q/Q- EarningsMar 26 AMC Avg Volume90.94K Price1.61
SMA200.60% SMA50-12.44% SMA200-46.66% Trades Volume114,744 Change7.00%
Date Action Analyst Rating Change Price Target Change
Oct-19-20Initiated Cantor Fitzgerald Overweight $10
Sep-22-20Initiated Alliance Global Partners Buy $12
Feb-20-20Initiated Maxim Group Buy $16
Feb-06-20Reiterated H.C. Wainwright Buy $6 → $9
Jan-09-20Initiated Piper Sandler Overweight $10
Mar-01-19Initiated RBC Capital Mkts Outperform $6
Nov-16-18Initiated B. Riley FBR Buy $5
Dec-13-17Reiterated H.C. Wainwright Buy
Oct-23-17Resumed ROTH Capital Buy $5
Sep-07-17Upgrade H.C. Wainwright Neutral → Buy $1 → $4
Mar-27-24 08:26AM
Mar-26-24 08:53PM
04:01PM
Mar-18-24 04:30PM
Jan-31-24 04:01PM
08:36AM Loading…
Jan-26-24 08:36AM
08:00AM
Dec-09-23 06:30PM
Nov-30-23 04:59PM
Nov-10-23 11:21AM
Nov-09-23 04:17PM
04:00PM
Nov-02-23 09:00AM
Oct-30-23 09:15AM
Oct-26-23 07:11AM
07:30AM Loading…
Oct-23-23 07:30AM
Oct-16-23 07:30AM
Sep-18-23 07:45AM
Sep-06-23 07:45AM
Aug-24-23 07:30AM
Aug-10-23 04:08PM
04:02PM
Jul-27-23 04:04PM
Jun-26-23 04:05PM
Jun-10-23 12:00PM
Jun-05-23 07:30AM
May-31-23 07:30AM
May-25-23 04:14PM
May-23-23 05:30PM
May-21-23 10:03AM
07:28AM Loading…
May-11-23 07:28AM
May-08-23 04:13PM
04:01PM
May-04-23 07:01AM
Apr-24-23 07:01AM
Apr-10-23 04:01PM
Mar-28-23 04:01PM
09:40AM
Mar-27-23 08:45AM
Mar-23-23 04:44PM
Mar-10-23 06:44PM
Mar-09-23 04:05PM
Mar-02-23 07:30AM
Jan-30-23 07:00AM
Dec-30-22 08:02AM
Dec-28-22 07:30AM
Dec-12-22 06:15AM
Dec-11-22 09:00AM
Dec-07-22 04:05PM
Nov-14-22 07:30AM
Nov-03-22 09:10AM
Nov-01-22 04:01PM
Oct-18-22 04:01PM
Sep-30-22 08:59AM
Sep-29-22 11:09AM
Sep-28-22 01:47PM
Sep-27-22 11:44AM
10:13AM
Sep-21-22 06:32PM
Sep-20-22 09:49AM
Sep-19-22 12:28PM
Sep-14-22 07:30AM
Sep-13-22 03:45PM
08:44AM
07:30AM
Sep-12-22 07:30AM
Aug-30-22 07:30AM
Aug-02-22 04:01PM
Jul-27-22 07:30AM
Jul-23-22 08:08AM
Jul-19-22 04:01PM
Jun-27-22 07:30AM
Jun-02-22 08:10PM
05:30PM
May-31-22 04:15PM
May-25-22 08:30AM
May-12-22 10:00AM
May-09-22 04:01PM
May-04-22 07:30AM
May-03-22 07:30AM
May-02-22 04:10PM
Apr-25-22 07:30AM
Apr-07-22 07:00AM
Mar-31-22 07:30AM
Mar-22-22 04:01PM
Mar-08-22 07:30AM
Mar-01-22 07:30AM
Feb-13-22 06:39AM
Dec-31-21 01:50PM
Dec-29-21 07:30AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-20-21 07:30AM
Dec-16-21 09:14AM
Dec-15-21 04:09AM
Dec-14-21 07:38AM
Dec-13-21 04:30PM
Dec-10-21 10:17AM
Dec-09-21 11:18AM
Dec-08-21 09:38AM
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seizinger Bernd R.DirectorSep 22 '23Buy3.1417,00053,38017,000Sep 25 05:03 PM